Skip to main content
Caplight Logo









Salspera, Inc.

Salspera, Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://salspera.com

Last Round

IPO

Feb 2, 2026

Total Funding Raised

$680,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Salspera, Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. It has raised $680,000.

Salspera, Inc. is a biotechnology company that develops live biopharmaceutical immunotherapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Salspera, Inc. Comparables

Compare Salspera, Inc. with similar companies based on industry and business-model similarity.

Salspera, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Actym Therapeutics
88%
Ernest Pharmaceuticals
84%
Prokarium
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Salspera, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOFeb 2, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Eddie Moradian

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    $85M raised in IPO round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Salspera, Inc. Filings

Explore SEC and related filing metadata, where available.

Salspera, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Salspera, Inc.'s valuation, stock price, and market status.

Is Salspera, Inc. a public or private company?

Salspera, Inc. is a private company.

What is the current stock price of Salspera, Inc.?

Salspera, Inc. is a private company, so its shares have no public market price. Caplight tracks Salspera, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Salspera, Inc. worth (valuation)?

Valuation information for Salspera, Inc. is not publicly available.

Can I buy Salspera, Inc. stock?

Salspera, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Salspera, Inc.'s last funding round?

Salspera, Inc.'s most recent funding round was IPO on February 2, 2026.

Who are the main investors in Salspera, Inc.?

Investor information for Salspera, Inc. is not publicly disclosed.

Will Salspera, Inc. IPO soon?

No public IPO plans have been announced for Salspera, Inc..

How can I track Salspera, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Salspera, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range2
Year Founded2017
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?